Background: Gastric non-Helicobacter pylori helicobacters (NHPH) naturally colonize the stomach of animals. In humans, infection with these bacteria is associated with chronic active gastritis, peptic ulceration and MALT-lymphoma. H. bizzozeronii belongs to these NHPH and its prevalence in children is unknown. Case presentation: This case report describes for the first time a NHPH infection in a 20-month-old girl with severe gastric disorders in Mexico. The patient suffered from melena, epigastric pain, and bloating. Gastroscopy showed presence of a Hiatus Hill grade I, a hemorrhagic gastropathy in the fundus and gastric body, and a Forrest class III ulcer in the fundus. Histopathologic examination revealed a chronic active gastritis with presence of long, spiral-shaped bacilli in the glandular lumen. Biopsies from antrum, body and incisure were negative for presence of H. pylori by culture and PCR, while all biopsies were positive for presence of H. bizzozeronii by PCR. Most likely, infection occurred through intense contact with the family dog. The patient received a triple therapy consisting of a proton pump inhibitor, clarithromycin, and amoxicillin for 14 days, completed with sucralfate for 6 weeks, resulting in the disappearance of her complaints. Conclusion: The eradication could not be confirmed, although it was suggested by clear improvement of symptoms. This case report further emphasizes the zoonotic importance of NHPH. It can be advised to routinely check for presence of both H. pylori and NHPH in human patients with gastric complains.
In this study, we assessed the presence of Epstein-Barr virus (EBV) in gastric samples derived from pediatric patients with dyspeptic symptoms, aiming to understand whether EBV participates in the development of early gastric lesions influencing chronic inflammation, in conjunction with the Helicobacter pylori (Hp) bacterium. We analyzed EBV load in 236 gastric biopsies derived from 186 pediatric patients with chronic dyspepsia and compared it with EBV serology, Hp load and serology, and with immune cell infiltration. We found that 7.5% of patients were positive for EBV load, ranging from 240 to 29,685 genomic copies/μg of DNA. Hp genomic sequences were found in 24.7% of patients. EBV positive samples did not correlate with Hp status and were characterized by absent to moderate immune cell infiltration. To our knowledge, this is the first study addressing EBV load in the stomach in a large cohort of pediatric patients with dyspeptic symptoms, providing evidence of EBV localization in the gastric mucosa in early inflammatory lesions. The lack of correlation between EBV and both Hp infection and inflammation is perhaps explained by independent pathogenic mechanisms or because of the randomness of the gastritis sampling. This is also supported by a moderate association between EBV load and serology.
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction and susceptibility to Staphylococcus aureus colonization. Biofilm formation modifies antibiotic resistance and the host immune response. This longitudinal study analyzed antimicrobial susceptibility and biofilm formation in 136 S. aureus isolates obtained over 18 months from lesional, nonlesional, and nasal samples of 26 pediatric patients with moderate-to-severe AD. Antimicrobial susceptibility testing was determined by the disk diffusion method, and biofilm production was quantified using a crystal violet microtiter assay. Clinical parameters, including disease severity, treatment response, and the administration of dilute bleach baths, were evaluated in relation to bacterial characteristics. Overall, 60.2% of isolates exhibited moderate-to-strong biofilm production, significantly associated with severe AD at baseline (p = 0.01), lack of clinical improvement (p = 0.04), and persistent moderate-to-severe disease (p = 0.01). Resistance rates for penicillin, gentamicin, clindamycin, and erythromycin exceeded 15%. Isolates from patients using dilute bleach baths showed greater resistance to ciprofloxacin (p < 0.0001) and exhibited constitutive or inducible macrolide–lincosamide–streptogramin B (MLSB) resistance, with ermA detected in 80% of inducible cases. In conclusion, S. aureus biofilm formation is linked to disease severity and treatment failure in pediatric AD, underscoring the importance of culture-guided, targeted therapeutic strategies.
Helicobacter pylori is a Gram-negative bacterium that inhabits the gastric mucosa and infects over 50% of the global population, predominantly in developing countries. The organism causes chronic gastritis and is associated with gastric carcinoma. Traditional antibiotic treatment promotes intestinal dysbiosis and antimicrobial resistance. In this context, postbiotics—the metabolic end products of probiotics—have been shown to be powerful antimicrobial alternatives. The excretion/secretion (E/S) products and exopolysaccharides (EPSs) of lactic acid bacteria (LAB) have been found to exhibit inhibitory activity against pathogens. EPSs are complex sugar polymers involved in biofilm formation and stress resistance, and their activity varies with culture conditions. Most notably, no digestible carbohydrates, such as those present in agave-derived Graminan-Type fructans (GTFs), are effective carbon sources for LAB, which, in turn, affects their metabolic end products. In this study, the E/S products and EPSs of the INP_MX_001 LAB strain were assayed for antimicrobial and antibiofilm activity after growth with three structurally different GTFs. Results indicated potent inhibition of H. pylori survival and biofilm formation in vitro. Our results confirm the promise of using LAB-derived postbiotics, particularly those produced with GTFs, as a novel, non-antibiotic means of combating H. pylori colonization and infection.
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction and susceptibility to Staphylococcus aureus colonization. Biofilm formation alters antibiotic resistance and the immune response. This study examines the antimicrobial susceptibility patterns and biofilm formation of S. aureus isolates from pediatric AD patients. Methods: A prospective longitudinal observational study was conducted with 136 S. aureus isolates collected from 26 pediatric patients with moderate-to-severe AD over 18 months. Isolates were obtained from both lesional and nonlesional skin and from nares. Antimicrobial susceptibility was evaluated using the disk diffusion method, whereas biofilm production was quantified using a crystal violet microtiter assay. Clinical characteristics, including AD severity, response to treatment, and the use of adjunctive dilute bleach baths, were analyzed for associations with S. aureus features. Results: Of the isolates, 60.2% exhibited moderate-to-strong biofilm production, which was associated with severe AD at baseline (p=0.01), lack of clinical improvement (p=0.04), and persistent moderate-severe disease (p=0.01). The antimicrobial resistance rates for penicillin, gentamicin, clindamycin, and erythromycin exceeded 15%. Isolates from patients receiving dilute bleach baths presented greater resistance to ciprofloxacin (p<0.0001) and constitutive and inducible macrolide-lincosamide-streptogramin B resistance (MLSB). Inducible MLSB was associated with the ermA gene in 80% of the cases. Conclusions: S. aureus biofilm formation correlates with disease severity and treatment resistance in pediatric AD patients. These findings highlight the need for culture-guided therapy and emphasize the importance of tailored strategies to manage S. aureus colonization and infection in AD patients. Importance: In this longitudinal study of 136 S. aureus isolates from 26 pediatric patients with atopic dermatitis, we examined the antimicrobial susceptibility patterns and biofilm formation of S. aureus . We found 60.2% exhibited moderate-to-strong biofilm production, which was significantly associated with severe atopic dermatitis at baseline, lack of clinical improvement, and persistent moderate-severe disease. The antimicrobial resistance rates for penicillin, gentamicin, clindamycin, and erythromycin were suboptimal exceeding 15%. Isolates from patients receiving dilute bleach baths presented greater resistance to ciprofloxacin and constitutive and inducible MLSB resistance. Inducible MLSB resistance was associated with the ermA gene in 80% of the cases. These findings emphasize the importance of culture-guided therapy in skin and soft tissue infections associated to atopic dermatitis, the need for tailored strategies to manage S. aureus colonization and infection in AD patients, and of developing alternative treatments targeting biofilm and quorum-sensing mechanisms.